Dr. Norma Angélica Noguez Méndez holds a Bachelor's degree in Pharmaceutical Biological Chemistry from UAM Xochimilco (1987), a Master's degree in Pharmacy with a concentration in Biopharmacy from the Faculty of Chemistry at the Universidad Nacional Autónoma de México (1998), and a Ph.D. in Chemical Engineering from the UNAM Faculty of Chemistry (2015). She serves as a researcher in the Department of Biological Systems and a faculty member in the Pharmaceutical Biological Chemistry undergraduate program, as well as the Master's and Doctoral programs in Pharmaceutical Sciences at UAM Xochimilco. She served as Head of the Pharmaceutical Technology Research Area from 2014 to 2019 and has been Coordinator of the Pharmaceutical Biological Chemistry undergraduate program since 2022.

In academic committees and regulatory bodies, she participated in the Academic Committee for the Master's and Doctoral Programs in Pharmaceutical Sciences (2015–2025) and has served on the Social Service Committee for the Pharmaceutical Biological Chemistry undergraduate program since 2022. She has been a full member of the Pharmaceutical Preparations Committee of the Pharmacopeia of the United Mexican States (FEUM) since 1997, and a member of both the National Technical Committee for Standardization in Nanotechnologies and the ISO TC 229 Mirror Committee for International Standardization since 2010.

Her institutional collaborations include delivering training courses on medicine dispensing for the Mexico City Secretariat of Social Development (2017), participating in the international COPHELA Project (Cooperation in Quality Assurance for Pharmacy Education and Training between Europe and Latin America, 2018–2022), and evaluating academic curricula in Pharmacy and Pharmaceutical Biological Chemistry for CIFRHUS from 2010 to 2025. She co-authored volumes on the characterization of pharmaceutical materials in the CBS Texts Series (Particle Size, Vol. 1, 2020; Zeta Potential, Vol. 2, 2020) and contributed three chapters (Pharmaceutical Services, Current Status of Pharmaceutical Services in Mexico, and Pharmacotherapeutic Monitoring) to the book Servicios Farmacéuticos (2022), published by the National College of Pharmaceutical-Biological Chemists of Mexico.

Her primary research lines encompass the technological development of pharmaceutical dosage forms and the adaptation of technology for obtaining and purifying pharmaceutical-grade raw materials. Within this framework, she leads the research project "Development and Evaluation of Micro-processes (Microfluidics) for Obtaining Innovative Pharmaceutical Dosage Forms," covering polymer synthesis for oxygen-carrier polymersomes and drug delivery systems, micro-process applications with natural actives, analytical method validation, and dissolution profiling for bioequivalence studies. To date, her research output includes 6 patent developments, 35 social service projects supervised, 12 graduate theses directed, and 20 peer-reviewed national, international, and outreach publications.